83 related articles for article (PubMed ID: 17998031)
1. Physiologic roles of 11beta-hydroxysteroid dehydrogenase type 2 in kidney: a comment on the article of Isomura et al.
Fenske M
Metabolism; 2007 Dec; 56(12):1749. PubMed ID: 17998031
[No Abstract] [Full Text] [Related]
2. Physiologic roles of 11beta-hydroxysteroid dehydrogenase type 2 in kidney.
Isomura Y; Mune T; Morita H; Suwa T; Takada N; Yamamoto Y; Takeda J
Metabolism; 2006 Oct; 55(10):1352-7. PubMed ID: 16979406
[TBL] [Abstract][Full Text] [Related]
3. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
[TBL] [Abstract][Full Text] [Related]
4. In vivo measurement of renal 11beta-hydroxysteroid dehydrogenase type 2 activity.
Quinkler M; Oelkers W; Diederich S
J Clin Endocrinol Metab; 2000 Dec; 85(12):4921-3. PubMed ID: 11134165
[No Abstract] [Full Text] [Related]
5. Altered expression of 11beta-hydroxysteroid dehydrogenases in rheumatoid arthritis synovial cells: comment on the article by Haas et al.
Schmidt M; Straub RH
Arthritis Rheum; 2007 May; 56(5):1720-1. PubMed ID: 17469166
[No Abstract] [Full Text] [Related]
6. An HPLC method for the determination of the free cortisol/cortisone ratio in human urine.
Al Sharef O; Feely J; Kavanagh PV; Scott KR; Sharma SC
Biomed Chromatogr; 2007 Nov; 21(11):1201-6. PubMed ID: 17590867
[TBL] [Abstract][Full Text] [Related]
7. Urinary cortisol/cortisone ratios in hypertensive and normotensive cats.
Walker DJ; Elliott J; Syme HM
J Feline Med Surg; 2009 Jun; 11(6):442-8. PubMed ID: 19058985
[TBL] [Abstract][Full Text] [Related]
8. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
[TBL] [Abstract][Full Text] [Related]
9. Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2.
Gong R; Morris DJ; Brem AS
Life Sci; 2008 Mar; 82(11-12):631-7. PubMed ID: 18261751
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
Stegk JP; Ebert B; Martin HJ; Maser E
Mol Cell Endocrinol; 2009 Mar; 301(1-2):104-8. PubMed ID: 19022342
[TBL] [Abstract][Full Text] [Related]
11. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
Müssig K; Remer T; Fritsche A; Häring HU; Maser-Gluth C
Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
[TBL] [Abstract][Full Text] [Related]
12. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds.
Blum A; Favia AD; Maser E
Mol Cell Endocrinol; 2009 Mar; 301(1-2):132-6. PubMed ID: 18822345
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of 11beta-hydroxysteroid dehydrogenase type-1 and -2 gene transcription by proinflammatory cytokines in vascular smooth muscle cells.
Tsugita M; Iwasaki Y; Nishiyama M; Taguchi T; Shinahara M; Taniguchi Y; Kambayashi M; Terada Y; Hashimoto K
Life Sci; 2008 Sep; 83(11-12):426-32. PubMed ID: 18692075
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
Su X; Vicker N; Trusselle M; Halem H; Culler MD; Potter BV
Mol Cell Endocrinol; 2009 Mar; 301(1-2):169-73. PubMed ID: 18775471
[TBL] [Abstract][Full Text] [Related]
16. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
Roche D; Carniato D; Leriche C; Lepifre F; Christmann-Franck S; Graedler U; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E
Bioorg Med Chem Lett; 2009 May; 19(10):2674-8. PubMed ID: 19395260
[TBL] [Abstract][Full Text] [Related]
17. Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells.
Gong R; Morris DJ; Brem AS
Steroids; 2008 Oct; 73(11):1187-96. PubMed ID: 18573267
[TBL] [Abstract][Full Text] [Related]
18. Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients.
Henschkowski J; Stuck AE; Frey BM; Gillmann G; Dick B; Frey FJ; Mohaupt MG
Am J Hypertens; 2008 Jun; 21(6):644-9. PubMed ID: 18443572
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
Yang H; Dou W; Lou J; Leng Y; Shen J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087
[TBL] [Abstract][Full Text] [Related]
20. Pentanol derivatives from basidiomycete Catathelasma imperiale and their 11beta-hydroxysteroid dehydrogenases inhibitory activity.
Zhang L; Shen Y; Zhu HJ; Wang F; Leng Y; Liu JK
J Antibiot (Tokyo); 2009 May; 62(5):239-42. PubMed ID: 19329984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
